Evaxion A EVAX
NASDAQ EVAX
$3.28 +0.01 (+0.31%)
At close: Sep 30, 2026 · 4:00 PM EDT

Evaxion A (EVAX) Change in Receivables (2023 - 2024)

Updated

Evaxion A (EVAX) recorded Change in Receivables of $178,000 in FY2025, compared with -$167,000 in FY2024.

Analysis

Evaxion A (EVAX) Change in Receivables (2023 - 2024) Analysis & Trends

Starting with FY2018, Evaxion A's Change in Receivables history includes 8 years.

  • Annual Change in Receivables has a five-year compound annual growth rate of -41.1% (FY2020 to FY2025).
  • Annual Change in Receivables has ranged from -$1.86 million in FY2021 to $259,000 in FY2023 over the past five years.
  • Per Business Quant data, EVAX's Change in Receivables was -$167,000 in FY2024, $259,000 in FY2023, -$1.49 million in FY2022 and -$1.86 million in FY2021.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change Receivables (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 1.35 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 1.37 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn -
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 1.09 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 333.00 Mn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn -
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 140.20 Mn
10 Evaxion A 21.02 Mn -45.23 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2024 374,000.00
Dec 31, 2023 1.11 Mn
API Access

Evaxion A Change in Receivables API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=change-in-receivables&ticker=EVAX&period=max&api_key=YOUR_API_KEY